Relations between neurometabolism and clinical biomarkers in patients with metabolic disease
Relations between neurometabolism and clinical biomarkers in patients with metabolic disease
About this item
Full title
Author / Creator
Publisher
Switzerland: Frontiers Media S.A
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: Frontiers Media S.A
Subjects
More information
Scope and Contents
Contents
The global prevalence of metabolic diseases, including hypertension, type 2 diabetes mellitus (T2DM), gout, and obesity, has significantly increased over the past two decades. The brain plays a central role in regulating both human behavior and metabolism. Understanding the potential connections among these metabolic diseases and the involvement of...
Alternative Titles
Full title
Relations between neurometabolism and clinical biomarkers in patients with metabolic disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1ce02844b3ac4876962ec4cec57a2bc2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ce02844b3ac4876962ec4cec57a2bc2
Other Identifiers
ISSN
1662-453X,1662-4548
E-ISSN
1662-453X
DOI
10.3389/fnins.2025.1547010
